Open original FDA record ↗Recall record
- FDA identifier
- Z-0317-2027
- Company in FDA record
- Accriva Diagnostics, Inc.
- FDA classification date
- Oct 30, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Class II
Reason stated in the source
Microcoagulation test used to evaluate low dose heparin anticoagulation has a mispositioned or absent clot activating reagent, which may result in out-of-range high error code, or erroneously high results, which may lead retest, or overestimation of patient's anticoagulation, leading to inadequate anticoagulant therapy, which could result in thrombosis.
Source facts
- Action
- On 9/14/2026, recall notices were mailed to customers who were informed of the following: 1) Please forward this communication to those within your organization who need to be aware of this matter and verify they understand the procedure and can complete the enclosed forms. 2) Forward the enclosed customer notification to all other organizations where affected devices may have been transferred to. 3) Please check your inventory and do not use affected lots. 4) Scrap/destroy all impacted cuvettes and/or boxes. 5) Complete and return the Acknowledgement and Receipt Form via email to ilsd_ra.na@werfen.com Questions about receiving credit, should be directed to Customer Service at 1-800-955-9525 or e-mail customerservice.na@werfen.com. Technical questions should be directed to Technical Services at 1-800-678-0710 Option 3 or email techsupport.na@werfen.com.
- Initiated
- 2026-09-14
- Root cause
- Process control
- Distribution
- Worldwide - US Nationwide distribution in the states of MA, MO, AK, WV, NJ, TX, VA, IL, NY and the countries of China, Colombia.
- Recall number
- Z-0317-2027
- Recall status
- Open, Classified
- CDRH record ID
- 222749
- FDA classified
- 2026-10-30
- Recall event number
- 99863